Details
|
YM Biosciences is a biopharmaceutical industry which focuses on developing drugs for the cure of cancer. YM Biosciences currently has four drug candidates in clinical processing of development such as: Norelin - a therapeutic vaccine used to stimulate the production of antibodies against GnRH in individuals; Tesmilifene - a small molecule anti-cancer drug; EGFr-epidermal growth factor receptor, which is indicated to treat epithelial cancers; RadioTheraCIM - a radio labelled humanized Monoclonal antibody targeting the epidermal growth factor receptor, for the treatment of brain cancers.
YM Biosciences also has 2 therapeutic cancer vaccines in the pre-clinical phase of development such as HER-1 and TGF - a cancer vaccine. YM was discovered in 1994 and is a publicly traded company under the stock symbol: YMI based in Mississauga, Canada.
|
